Natural Health Science News The latest news and top resources on natural health.

Acid Blockers

Posted May 1, 2017

Multimorbidity: Epidemiology and risk factors in the golestan cohort study, Iran a cross-sectional analysis.

Ahmadi, B., M. Alimohammadian, M. Yaseri, A. Majidi, M. Boreiri, F. Islami, H. Poustchi, et al. “Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis.” [In eng]. Medicine (Baltimore) 95, no. 7 (Feb 2016): e2756.

Randomised clinical trial: Vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis.

Ashida, K., Y. Sakurai, T. Hori, K. Kudou, A. Nishimura, N. Hiramatsu, E. Umegaki, and K. Iwakiri. “Randomised Clinical Trial: Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Vs. Lansoprazole for the Healing of Erosive Oesophagitis.” [In eng]. Aliment Pharmacol Ther 43, no. 2 (Jan 2016): 240-51.

Drugs for postmenopausal osteoporosis.

Drugs for Postmenopausal Osteoporosis. [In eng]. Med Lett Drugs Ther 56, no. 1452 (Sep 29 2014): 91-6.

Iron-based phosphate binders – A new element in management of hyperphosphatemia.

Pai, A. B., S. M. Jang, and N. Wegrzyn. “Iron-Based Phosphate Binders–a New Element in Management of Hyperphosphatemia.” [In eng]. Expert Opin Drug Metab Toxicol 12, no. 1 (2016): 115-27.

Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease – Interim results of an international multicentre trial.

Kappelle, W. F., A. J. Bredenoord, J. M. Conchillo, J. P. Ruurda, N. D. Bouvy, M. I. van Berge Henegouwen, P. W. Chiu, et al. “Electrical Stimulation Therapy of the Lower Oesophageal Sphincter for Refractory Gastro-Oesophageal Reflux Disease – Interim Results of an International Multicentre Trial.” [In eng]. Aliment Pharmacol Ther 42, no. 5 (Sep 2015): 614-25.

Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: A randomised controlled double-blind study.

Curcic, J., A. Schwizer, E. Kaufman, Z. Forras-Kaufman, S. Banerjee, A. Pal, G. S. Hebbard, et al. “Effects of Baclofen on the Functional Anatomy of the Oesophago-Gastric Junction and Proximal Stomach in Healthy Volunteers and Patients with Gerd Assessed by Magnetic Resonance Imaging and High-Resolution Manometry: A Randomised Controlled Double-Blind Study.” [In eng]. Aliment Pharmacol Ther 40, no. 10 (Nov 2014): 1230-40.

Electrical stimulation for gastroesophageal reflux disease: Current state of the art.

Kim, S. E., and E. Soffer. “Electrical Stimulation for Gastroesophageal Reflux Disease: Current State of the Art.” [In eng]. Clin Exp Gastroenterol 9 (2016): 11-9.

Gastroesophageal reflux disease after peroral endoscopic myotomy: Analysis of clinical, procedural and functional factors, associated with gastroesophageal reflux disease and esophagitis.

Familiari, P., S. Greco, G. Gigante, A. Cali, I. Boskoski, G. Onder, V. Perri, and G. Costamagna. “Gastroesophageal Reflux Disease after Peroral Endoscopic Myotomy: Analysis of Clinical, Procedural and Functional Factors, Associated with Gastroesophageal Reflux Disease and Esophagitis.” [In eng]. Dig Endosc 28, no. 1 (Jan 2016): 33-41.

Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers.

Ishimura, N., M. Mori, H. Mikami, S. Shimura, G. Uno, M. Aimi, N. Oshima, S. Ishihara, and Y. Kinoshita. “Effects of Acotiamide on Esophageal Motor Function and Gastroesophageal Reflux in Healthy Volunteers.” [In eng]. BMC Gastroenterol 15 (Sep 11 2015): 117.

Cholera outbreaks in Africa.

Mengel, M. A., I. Delrieu, L. Heyerdahl, and B. D. Gessner. “Cholera Outbreaks in Africa.” [In eng]. Curr Top Microbiol Immunol 379 (2014): 117-44.

The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis.

Gao, F., A. R. Hobson, Z. M. Shang, Y. X. Pei, Y. Gao, J. X. Wang, and W. N. Huang. “The Prevalence of Gastro-Esophageal Reflux Disease and Esophageal Dysmotility in Chinese Patients with Idiopathic Pulmonary Fibrosis.” [In eng]. BMC Gastroenterol 15 (Feb 19 2015): 26.

Symptomatic reflux disease: The present, the past and the future.

Boeckxstaens, G., H. B. El-Serag, A. J. Smout, and P. J. Kahrilas. “Republished: Symptomatic Reflux Disease: The Present, the Past and the Future.” [In eng]. Postgrad Med J 91, no. 1071 (Jan 2015): 46-54.

Clinical impact of esophageal function tests and argon plasma coagulation in heterotopic gastric mucosa of the esophagus and extraesophageal reflux symptoms – a prospective study.

Frieling, T., R. Kuhlbusch-Zicklam, C. Weingardt, J. Heise, C. Kreysel, M. Blank, and D. Muller. “Clinical Impact of Esophageal Function Tests and Argon Plasma Coagulation in Heterotopic Gastric Mucosa of the Esophagus and Extraesophageal Reflux Symptoms – a Prospective Study.” [In eng]. Z Gastroenterol 53, no. 2 (Feb 2015): 101-7.

Discussing the influence of electrode location in the result of esophageal prolonged pH monitoring.

Felix, V. N., I. Yogi, D. Senday, F. T. Coimbra, D. Pares, V. Garcia, and C. E. Garcia. “Discussing the Influence of Electrode Location in the Result of Esophageal Prolonged Ph Monitoring.” [In eng]. BMC Gastroenterol 14 (Apr 04 2014): 64.

Helicobacter pylori, HIV and gastric hypochlorhydria in the Malawian population.

Geraghty, J., A. Thumbs, A. Kankwatira, T. Andrews, A. Moore, R. Malamba, N. Mtunthama, et al. “Helicobacter Pylori, Hiv and Gastric Hypochlorhydria in the Malawian Population.” [In eng]. PLoS One 10, no. 8 (2015): e0132043.

Endoscopic findings for predicting gastric acid secretion status.

Hatta, W., K. Iijima, T. Koike, Y. Kondo, N. Ara, K. Asanuma, K. Uno, et al. “Endoscopic Findings for Predicting Gastric Acid Secretion Status.” [In eng]. Dig Endosc 27, no. 5 (Jul 2015): 582-9.

Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: A population-based retrospective cohort study.

Almario, C. V., D. C. Metz, K. Haynes, and Y. X. Yang. “Risk of Community-Acquired Pneumonia in Patients with a Diagnosis of Pernicious Anemia: A Population-Based Retrospective Cohort Study.” [In eng]. Eur J Gastroenterol Hepatol 27, no. 11 (Nov 2015): 1259-64.

Probiotics in Helicobacter pylori-induced peptic ulcer disease.

Boltin, D. “Probiotics in Helicobacter Pylori-Induced Peptic Ulcer Disease.” [In eng]. Best Pract Res Clin Gastroenterol 30, no. 1 (Feb 2016): 99-109.

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Iwakiri, K., Y. Kinoshita, Y. Habu, T. Oshima, N. Manabe, Y. Fujiwara, A. Nagahara, et al. “Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease 2015.” [In eng]. J Gastroenterol 51, no. 8 (Aug 2016): 751-67.

Randomised clinical trial: The clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.

Sun, J., C. Yang, H. Zhao, P. Zheng, J. Wilkinson, B. Ng, and Y. Yuan. “Randomised Clinical Trial: The Clinical Efficacy and Safety of an Alginate-Antacid (Gaviscon Double Action) Versus Placebo, for Decreasing Upper Gastrointestinal Symptoms in Symptomatic Gastroesophageal Reflux Disease (Gerd) in China.” [In eng]. Aliment Pharmacol Ther 42, no. 7 (Oct 2015): 845-54.

Novel surgical options for gastroesophageal reflux disease.

Chiu, J., and E. Soffer. “Novel Surgical Options for Gastroesophageal Reflux Disease.” [In eng]. Expert Rev Gastroenterol Hepatol 9, no. 7 (Jul 2015): 943-51.

Vonoprazan: a novel potassium-competitive acid blocker.

Sugano, K. “[Vonoprazan: A Novel Potassium-Competitive Acid Blocker].” [In jpn]. Nihon Rinsho 73, no. 7 (Jul 2015): 1163-8.

Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis..

Maret-Ouda, J., P. Konings, J. Lagergren, and N. Brusselaers. “Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis.” [In eng]. Ann Surg 263, no. 2 (Feb 2016): 251-7.

Effect of GutsyGum(tm), A Novel Gum, on Subjective Ratings of Gastro Esophageal Reflux Following A Refluxogenic Meal.

Brown, R., C. H. Sam, T. Green, and S. Wood. “Effect of Gutsygum(Tm), a Novel Gum, on Subjective Ratings of Gastro Esophageal Reflux Following a Refluxogenic Meal.” [In eng]. J Diet Suppl 12, no. 2 (Jun 2015): 138-45.

Ayurvedic management of achalasia.

Rastogi, S., and P. Chaudhari. “Ayurvedic Management of Achalasia.” [In eng]. J Ayurveda Integr Med 6, no. 1 (Jan-Mar 2015): 41-4.

Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.

Hwang, J. J., D. H. Lee, A. R. Lee, H. Yoon, C. M. Shin, Y. S. Park, and N. Kim. “Characteristics of Gastric Cancer in Peptic Ulcer Patients with Helicobacter Pylori Infection.” [In eng]. World J Gastroenterol 21, no. 16 (Apr 28 2015): 4954-60.

Partnership in optimizing management of reflux symptoms: A treatment algorithm for over-the-counter proton-pump inhibitors.

Boardman, H. F., B. C. Delaney, and S. Haag. “Partnership in Optimizing Management of Reflux Symptoms: A Treatment Algorithm for over-the-Counter Proton-Pump Inhibitors.” [In eng]. Curr Med Res Opin 31, no. 7 (2015): 1309-18.

Prevalence of Helicobacter pylori in benign gastric ulcers in a cohort of Sri Lankan patients.

Wijetunge, S., R. Kotakadeniya, F. Noordeen, S. M. Buharideen, B. Samarasinghe, A. Dharmapala, and K. B. Galketiya. “Prevalence of Helicobacter Pylori in Benign Gastric Ulcers in a Cohort of Sri Lankan Patients.” [In eng]. Ceylon Med J 60, no. 4 (Dec 2015): 152-4.

The prevalence of Helicobacter pylori infection in patients with gastric and duodenal ulcers – a 10-year, single-centre experience.

Serin, A., E. Tankurt, C. Sarkis, and I. Simsek. “The Prevalence of Helicobacter Pylori Infection in Patients with Gastric and Duodenal Ulcers – a 10-Year, Single-Centre Experience.” [In eng]. Prz Gastroenterol 10, no. 3 (2015): 160-3.

CLINICAL AND ENDOSCOPIC, MORPHOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES OF GASTRIC ULCER IN H. PYLORI-INFECTED INDIVIDUALS RECEIVING CYTOTOXIC THERAPY.

Sazonova, O. V., I. L. Davydkin, A. M. Osadchuk, and T. A. Gritsenko. “[Clinical and Endoscopic, Morphologic and Immunohistochemical Features of Gastric Ulcer in H. Pylori-Infected Individuals Receiving Cytotoxic Therapy].” [In rus]. Eksp Klin Gastroenterol, no. 2 (2016): 18-24.